Alphabet, Campbell, Expedia: Stocks That Defined the Week The study is the first time Sage-217 "has missed on a major depression trial and thus, a major surprise to investors," SVB Leerink analysts said in a note to clients. Slack Technologies Inc. Investors messaged Slack Technologies Inc. the equivalent of a smiley-face emoji after the chat app company said it added more large corporate users for

Get breaking news and analysis on Sage Therapeutics, Inc. (SAGE) stock, price quote and chart, trading and investing tools. SAGE - Stock quote for SAGE THERAPEUTICS, INC. - MSN Money View the latest SAGE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SAGE THERAPEUTICS, INC.. Ask Sage - Opening and closing stock Sage Accounts automatically calculates your cost of sales for you on your profit and loss, and produces accurate net and gross profits if you post the opening and closing stock journals. The journal also updates the stock nominal code to show the actual value of the stock on your balance sheet. Sage... (SAGE) Stock Price VWAP | Premarket | After Hours

Sage Therapeutics Announces Inducement Grants Under NASDAQ ...

Sage Therapeutics Inc. Research & Ratings (SAGE) | Barron's View today's stock price, news and analysis for Sage Therapeutics Inc. (SAGE). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Sage Therapeutics Stock Rises After Postpartum Depression ... Sage Therapeutics could have a $600 million drug on its hands, an analyst suggested Thursday as the stock rocketed to a record high on strong data in two postpartum depression trials.. X By the Sage Therapeutics (NASDAQ:SAGE) Ratings | Benzinga Jan 01, 2010 · Sage Therapeutics (NASDAQ: SAGE) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on

Sage Therapeutics Inc. Stock Price (SAGE) | Barron's

Is Sage Therapeutics a Good Stock to Buy Now? | The Motley ... Less than five years after its stock market debut, Sage Therapeutics (NASDAQ:SAGE) has earned its first new drug approval, and the company's market value is at an all-time high. The stock has

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither TradingDay.com nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

SAGE - Sage Therapeutics Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Sage Therapeutics, Inc. - SAGE - Stock Price Today - Zacks View Sage Therapeutics, Inc. SAGE investment & stock information. Get the latest Sage Therapeutics, Inc. SAGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SAGE Stock Quote - SAGE Therapeutics, Inc. Stock Price Today SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of Sage Therapeutics - SAGE - Stock Price & News | The Motley ... Is Sage Therapeutics a Good Stock to Buy Now? Cory Renauer | Mar 20, 2019 Earning the first FDA approval for treating postpartum depression is a big step, but it's hardly an express ticket to

All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange

Annual Statement of Changes in Beneficial Ownership (5) After Hours Last Trade Last $ 68.08 0.00 (0.00 %) Annual Statement of Changes in Beneficial Ownership (5) FORM 5 SAGE) Historical Stock Chart. 1 Year : From Feb 2019 to Feb 2020. Sage Therapeutics (NASDAQ:SAGE) Intraday Stock Chart. Today : Saturday 15 February 2020. Latest SAGE Messages. Alphabet, Campbell, Expedia: Stocks That Defined the Week The study is the first time Sage-217 "has missed on a major depression trial and thus, a major surprise to investors," SVB Leerink analysts said in a note to clients. Slack Technologies Inc. Investors messaged Slack Technologies Inc. the equivalent of a smiley-face emoji after the chat app company said it added more large corporate users for Pre-Open Movers 09/12: (ALDX) (QTNT) (CTIC) Higher; (SAGE ... Today's Pre-Open Movers Aldeyra Therapeutics, Inc. (NASDAQ: ALDX ) 52.9% HIGHER ; announced positive results from a Phase 2a clinical trial of topical ocular ADX-102 in patients with dry eye disease. Sage Therapeutics, Inc. (SAGE) Stock Price, Quote, History ...

Sage Therapeutics, Inc. Common Stock (SAGE) After-Hours ... Sage Therapeutics, Inc. Common Stock (SAGE) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Sage Therapeutics stock rises after FDA approves first ... Mar 19, 2019 · Shares of Sage Therapeutics jumped more than 5 percent after hours Tuesday based on news that the FDA approved the first postpartum depression drug called Zulresso. Zulresso is an IV injection used to treat the sometimes life-threatening condition Sage Therapeutics, Inc. Common Stock (SAGE) Real-Time ... SAGE's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low